Bob Bollinger, MD, MPH

Role: 
Faculty
Raj and Kamla Gupta Professor of Infectious Diseases, Professor of Medicine, Public Health, and Nursing

Dr. Bollinger is the Raj and Kamla Gupta Professor of Infectious Diseases at the Johns Hopkins University (JHU) School of Medicine. He holds joint appointments in International Health at the Johns Hopkins (JH) Bloomberg School of Public Health, and in Community Public Health at the JH School of Nursing.  From 2005-2022, he was the Founding Director of the JH Center for Clinical Global Health Education (now CCGHE-ID), which was the home of the Johns Hopkins Division of Infectious Diseases research program in Pune, India until the establishment of the Center for Infectious Diseases in India (CIDI).  He is Associate Director for Medicine of the JH Center for Global Health and is a member of the Faculty Steering Committee of the Johns Hopkins Gupta Klinsky India Institute.  Is a member of the faculty advisory group for the JH Precision Medicine Center of Excellence for COVID-19 and the JH Center for Innovative Diagnostics in Infectious Diseases (CDID).  He has served as a member of the US Presidential Advisory Council for HIV/AIDS (PACHA), the PACHA International Sub-committee, the Institute of Medicine Forum on Public-Private Partnerships for Global Health and Safety, and the US National Institutes of Health (NIH) Fogarty International Center Advisory Board.

Dr. Bollinger has worked for more than 40 years with partners in India on a wide range of public health, clinical research, and education programs, including projects focused on HIV/AIDS, malaria, tuberculosis, leprosy, dengue, antibiotic resistant infections, COVID-19 and other emerging diseases. His research interests include identifying biological and behavioral risk factors for HIV and TB transmission; characterizing the clinical progression and treatment of HIV, TB and related infections; development/evaluation of novel point-of-care diagnostics and implementation of research projects to optimize equitable access to healthcare capacity and delivery in resource-limited communities.

In 1991, he initiated an NIH-funded Indo-US HIV research program in Pune, India, involving the National AIDS Research Institute/ICMR and the BJ Government Medical College. He has served as Principal Investigator for many NIH-supported studies and clinical trials in Pune, including the SWEN study, which led to changes in World Health Organization (WHO) guidelines for treatment of infants born to HIV positive mothers to prevent mother-to-child transmission. Under his 26 years as leader of the Hopkins India Fogarty International Research Training Program, short-term and degree training was provided to more than 140 visiting Indian scientists at JHU, and in-country training provided to more than 2,000 Indian scientists. His commitment to education has been honored with the Johns Hopkins Department of Medicine David M. Levine Excellence in Mentoring Award.

Dr. Bollinger is author of more than 220 peer-reviewed research publications and 15 book chapters, including the first and largest studies of risk factors for HIV transmission in India, the cloning and sequencing of the first HIV viruses from India, the only studies characterizing the primary immune response to HIV in India, and the demonstration of increased risk of HIV acquisition with recent HSV infection and lack of circumcision. Dr. Bollinger received an undergraduate degree from Haverford College, a Doctor of Medicine from Dartmouth Medical School, and a Master of Public Health from JH Bloomberg School of Public Health. He completed his internal medicine training at the University of Maryland Medical Systems, followed by a post-doctoral fellowship in infectious diseases at JHU School of Medicine. He is board certified by the American Board of Internal Medicine in internal medicine and infectious diseases. 

Patterns of TB drug-resistance in a tertiary care facility in Pune, India

Post Date: 
2013-07-18
   |   
Countries: 
Publication: 
Clinical Microbiology
Introduction:Globally, the emergence of multi-drug resistant tuberculosis (MDRTB) (defined as resistance to isoniazid (INH) and rifampicin (RIF) and extensively drug resistant (XDR-TB) (defined as resistance to INH, RIF, any fluoroquinolone and to at least one of the three injectable second...

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy

Post Date: 
2013-03-26
   |   
Clinical Sites: 
Publication: 
Clinical Infectious Diseases
Background: Combination antiretroviral therapy (cART) reduces genital tract human immunodeficiency virus type 1 (HIV-1) load and reduces the risk of sexual transmission, but little is known about the efficacy of cART for decreasing genital tract viral load (GTVL) and differences in sex or HIV...

Correlates of lower comprehension of informed consent among participants enrolled in a cohort study in Pune, India

Post Date: 
2013-03-15
   |   
Countries: 
Publication: 
International Health
Background: Optimum comprehension of informed consent by research participants is essential yet challenging. This study explored correlates of lower comprehension of informed consent among 1334 participants of a cohort study aimed at estimating HIV incidence in Pune, India. ...

Growth patterns among HIV-exposed infants receiving nevirapine prophylaxis in Pune, India

Post Date: 
2012-10-31
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
BMC Infectious Diseases
Background: India has among the highest rates of infant malnutrition. Few studies investigating the growth patterns of HIV-exposed infants in India or the impact of timing of HIV infection on growth in settings such as India exist. Methods: We used data from...

Pooled individual data analysis of five randomized trials of infant nevirapine prophylaxis to prevent breast-milk HIV-1 transmission

Post Date: 
2012-10-19
   |      |   
Clinical Sites: 
Publication: 
Clinical Infectious Diseases
Background: In resource-limited settings, mothers infected with human immunodeficiency virus type 1 (HIV-1) face a difficult choice: breastfeed their infants but risk transmitting HIV-1 or not breastfeed their infants and risk the infants dying of other infectious diseases or...

Evaluation of a multimodal, distance learning HIV management course for clinical care providers in India

Post Date: 
2012-10-01
   |   
Countries: 
Publication: 
Journal of the International Association of Providers of AIDS Care
Distance learning is an important tool for training HIV health workers. However, there is limited evidence on design and evaluation of distance learning HIV curricula and tools. We therefore designed, implemented, and evaluated a distance learning course on HIV management for clinical care...

Vitamin D deficiency is common among HIV-infected breastfeeding mothers in Pune, India, but not associated with mother-to-child HIV transmission

Post Date: 
2012-10-01
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
HIV Clinical Trials
A recent report from Tanzania demonstrated an increased risk of being HIV infected or of dying at birth among children born to breastfeeding mothers with low baseline vitamin D levels. We conducted a nested case-control study among HIV-infected pregnant women in western India to confirm the...

Authors’ response to Hanrahan et al CID article

Post Date: 
2012-05-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Clinical Infectious Diseases
Reply to letter

Predictors of mortality in hospitalized children with pandemic H1N1 influenza 2009 in Pune, India

Post Date: 
2012-04-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Indian Journal of Pediatrics
Objective: To analyse the factors associated with increased mortality among Indian Children with H1N1. Methods: Data were abstracted from available hospital records of children less than 12 y of age, who were admitted to Sassoon General Hospital in Pune, India, with...

Global health education for medical students: New learning opportunities and strategies

Post Date: 
2012-01-17
   |   
Publication: 
Medical Teacher
Background: A new course was offered to introduce basic global health concepts to all first year Johns Hopkins medical students, that took advantage of new distance learning capacity to connect medical students in Baltimore with students and faculty in Uganda, Ethiopia, Pakistan and India...

Sexually transmitted infections and risk behaviors among transgender persons (Hijras) of Pune, India

Post Date: 
2012-01-15
   |   
Countries: 
Publication: 
Journal of Acquired Immune Deficiency Syndromes
Background: The objectives of this cross-sectional study were to determine the prevalence of HIV and sexually transmitted infections (STI) in Hijras (self-identified transgenders of South Asia), study associated risk factors, and compare the prevalence with that in heterosexual men and men...

Impact of maternal human immunodeficiency virus infection on pregnancy and birth outcomes in Pune, India

Post Date: 
2011-12-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
AIDS Care
Little is known about birth outcomes for HIV-infected women in India. We examine maternal and neonatal birth outcomes in HIV-infected women within the context of enhanced pre-natal care associated with a randomized clinical trial conducted in Pune, India. Birth outcomes of 212 HIV-infected...

Symptom screening among HIV-infected pregnant women is acceptable and has high negative predictive value for active tuberculosis

Post Date: 
2011-11-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
Clinical Infectious Diseases
Symptom screening is a recommended component of intensified case-finding (ICF) for pulmonary tuberculosis (TB) among HIV-infected individuals. Symptomatic individuals are further investigated to either exclude or diagnose pulmonary TB, thus reducing the number of individuals requiring costly...

Prevention of HIV-1 infection with early antiretroviral therapy

Publication: 
New England Journal of Medicine
Background: Antiretroviral therapy that reduces viral replication could limit the transmission of human immunodeficiency virus type 1 (HIV-1) in serodiscordant couples. Methods: In nine countries, we enrolled 1763 couples in which one partner was HIV-1–positive and the other was HIV-1–negative; 54...

High rates of all-cause and gastroenteritis-related hospitalization morbidity and mortality among HIV-exposed Indian infants

Post Date: 
2011-07-15
   |   
Countries: 
   |   
Clinical Sites: 
Publication: 
BMC Infectious Diseases
Background: HIV-infected and HIV-exposed, uninfected infants experience a high burden of infectious morbidity and mortality. Hospitalization is an important metric for morbidity and is associated with high mortality, yet, little is known about rates and causes of hospitalization among these...

A comparison of online versus on-site training in health research methodology: A randomized study

Post Date: 
2011-06-17
   |   
Countries: 
Publication: 
BMC Medical Education
Background: Distance learning may be useful for building health research capacity. However, evidence that it can improve knowledge and skills in health research, particularly in resource-poor settings, is limited. We compared the impact and acceptability of teaching two distinct content areas...

Building a global health education network for clinical care and research: the benefits and challenges of distance learning tools

Post Date: 
2011-06-15
Publication: 
Infectious Disease Clinics of North America
Expanding the capacity for clinical care and health research is a global priority and a global challenge. In disenfranchised communities facing the largest burden of disease, whether they be in rural Africa or in urban US, there is a great need for more well-trained, competent and dedicated health...

Mortality in HIV infected individuals in Pune, India

Post Date: 
2011-04-15
   |   
Countries: 
Publication: 
Indian Journal of Medical Research
Background & Objectives: With the presence of HIV epidemic for more than two decades in India, rise in the number of HIV related deaths is expected. Data on mortality in HIV infected individuals from prospective studies are scanty in India. We report here data on mortality in a...

Mixed methods evaluation of an international internet-based continuing medical education course for pediatric HIV providers in Pune, India

Post Date: 
2011-04-09
   |   
Countries: 
Publication: 
Education for Health
Context: Studies of HIV care in Pune, a high-HIV-prevalence city in India, have shown that a significant proportion of practitioners were not adhering to national guidelines due to inadequate awareness and understanding. Objectives: This study examined the...

Twelve month follow-up of the SWEN randomized controlled trials: Differential impact of extended-dose nevirapine on mother-to-child transmission and infant death by maternal CD4 cell count

Post Date: 
2011-03-27
   |      |   
Clinical Sites: 
Publication: 
AIDS Care
Objectives: We previously reported combined analysis of 6-week and 6-month endpoints of three randomized controlled trials [Six Week Extended Dose Nevirapine (SWEN) trials] that compared extended-dose nevirapine through 6 weeks of age to single-dose nevirapine to prevent HIV transmission via...

Pages

Coronavirus live blog: Infectious disease expert Dr. Bob Bollinger answers your questions

Post Date: 
2020-04-10
Source: 
Fox News
Dr. Bob Bollinger, a professor of infectious diseases at the Johns Hopkins University School of Medicine, and consultant at emocha, a digital health startup using telehealth to monitor healthcare providers for COVID-19 symptoms.

Economy CANNOT restart until testing and contact tracing improves, says John Hopkins expert

Post Date: 
2020-04-09
Source: 
Brinkwire
The US economy cannot restart until testing and contact tracing for the killer disease improves, according to a John Hopkins infectious disease expert. Dr. Robert Bollinger of Johns Hopkins University warned that the ‘biggest issue’ in the fight against the pandemic is the...

Without Testing We Do Not Know Where the Virus is and Who Has It

Post Date: 
2020-04-09
Source: 
Background Briefing with Ian Matthews
We begin with the U.S. having close to 500,000 COVID-19 cases, by far the highest in the world, and at the same time one of the lowest rates of testing for the virus with less that 1% of the population tested so far. Dr. Robert Bollinger, Professor of Infectious Diseases at The Johns Hopkins...

US needs more testing to ‘transfer the economy ahead,’ says Johns Hopkins infectious disease expert

Post Date: 
2020-04-09
Source: 
Gruntstuff
Dr. Robert Bollinger, CCGHE Director, was interviewed for this report on the COVID-19 pandemic. Particularly, the U.S. needs more speedy testing and a greater system of contact tracing to decide who has been contaminated by COVID-19 and who has not, Bollinger mentioned on “Energy...

‘Every part of the country’ still at risk — ex-FDA chief urges US to stay united in coronavirus fight

Post Date: 
2020-04-09
Source: 
CNBC
Additional testing and contact tracing efforts are critical in obtaining the information needed to “move the economy forward,” Dr. Robert Bollinger of Johns Hopkins University told CNBC earlier this week. He pointed to contact tracing programs in Massachusetts and Maryland as examples that need to...

Economy CANNOT restart until testing and contact tracing improves in the US, says John Hopkins expert

Post Date: 
2020-04-08
Source: 
DailyMail
DailyMail
Dr. Robert Bollinger of Johns Hopkins University warned that the 'biggest issue' in the fight against the pandemic is the lack of testing, in an interview with CNBC Tuesday.

We need to expand access to rapid coronavirus testing and contact tracing: Johns Hopkins’ Dr. Bollinger

Post Date: 
2020-04-08
Source: 
CNBC
Bollinger-CNBC
Dr. Bob Bollinger appeared on CNBC's ‘Power Lunch’ to discuss coronavirus response.

New York has 12 TIMES more deaths than California because the state was slow to react to the pandemic, late on lockdown rules and advised residents to 'go on with' their lives, experts say

Post Date: 
2020-04-08
Source: 
Daily Mail
Dr. Robert Bollinger, CCGHE Director, was interviewed for this report on the COVID-19 pandemic. New York has more than 12 times the number of coronavirus deaths than California because the state was slow to react to the pandemic, late on lockdown rules and had advised residents to 'go on with'...

Diário coronavírus (07/04/20): Brasil registra 667 mortes por coronavírus e 13,7 mil casos

Post Date: 
2020-04-07
Source: 
ADVFN News (Brazil)
novo coronavírus (covid-19), segundo atualização do Ministério da Saúde divulgada hoje (7). O número representa um aumento de 20% em relação a ontem (6), quando foram registrados 553 óbitos. São Paulo segue como epicentro da pandemia, com 371 mortes, mais da metade dos óbitos de todo o país. O...

Le médecin de Johns Hopkins dit que les États-Unis ont encore besoin de tests supplémentaires

Post Date: 
2020-04-07
Source: 
News 24 (France)
L'amélioration dans ces domaines, ainsi que les efforts de distanciation sociale existants, "nous permettront vraiment de faire avancer l'économie, de reprendre le travail", a déclaré Bollinger, professeur de maladies infectieuses à la faculté de médecine de Johns Hopkins. ...

America's Newsroom: COVID-19 Report

Post Date: 
2020-04-02
Source: 
America's Newsroom with Sandra Smith and Ed Henry | FOX News
CCGHE Director Dr. Bob Bollinger is interviewed by Sandra Smith about healthcare workers and personal protective equipment during the COVID-19 response. ( Video not available )

Johns Hopkins deploys mobile health app to assist frontline health workers

Post Date: 
2020-04-02
Source: 
America's News Room | FOX News
Fox News Interview
FOX News: The emocha Mobile Health app is helping Hopkins health workers self monitor for COVID-19.

CCGHE Joins the Alliance of Artificial Intelligence in Healthcare

Post Date: 
2020-01-13
Dr. Robert Bollinger
“AAIH’s mission dovetails very well with our own work at Hopkins,” CCGHE Director Dr. Robert Bollinger noted.

Integrated Mobile Health Applications Show Promise for Quicker Care of Drug-Resistant TB in South Africa

Post Date: 
2019-10-11
Jane McKenzie-White
Researchers at Johns Hopkins and other institutions developed and tested a suite of mobile health applications that shows great promise for patient care and public health.

Industry Voices—Innovative tools needed to combat the world’s deadliest infectious disease

Post Date: 
2019-03-25
Source: 
FierceHealthcare
Robert Bollinger
In a FierceHealthcare World TB Day Op-ed, Bob Bollinger discusses what's needed to eliminate TB

Celebration of the Dedicated Participants and Staff of the REPRIEVE Study in Pune, India

Post Date: 
2019-02-18
REPRIEVE Team Members of the BJGMC Clinical Research Site
Staff and nearly 140 participants in the REPRIEVE study gathered for a community event in Pune, India

Bollinger Installed as Raj & Kamla Gupta Professor of Infectious Diseases

Post Date: 
2018-09-17
Raj and Kamla Gupta and Dr. Robert C. Bollinger
On September 5, CCGHE Director Dr. Robert C. Bollinger was installed as the inaugural recipient of the Raj and Kamla Gupta Professorship in Infectious Diseases, funded by the Ujala Foundation.

Doctor who tackled HIV and other infectious diseases in India honored

Post Date: 
2018-09-11
Source: 
India Abroad
Robert Bollinger
India Abroad article highlights the dedication of the Raj and Kamla Gupta Professorship in Infectious Diseases.

National Institutes of Health Awards emocha Mobile Health $1 Million for Multi-State Study

Post Date: 
2018-08-29
emocha-logo
Bob Bollinger: "It is critical for patients to take tuberculosis medication as prescribed, and research supports new adherence strategies. . . "

Infectious Diseases Can Be Tackled, Here are 3 Solutions

Post Date: 
2018-05-09
Source: 
The Hill
The Hill
Bob Bollinger: Quick delivery of care to sick patients eases the human impact and lowers the cost of disease.

Pages